参考文献/References:
[1] Chobanian N, Dietrich CS 3rd. Ovarian cancer[J]. Surg Clin North Am, 2008, 88: 285 299.
[2] 成文彩, 蔡桂茹, 顾美皎, 等. 髂内动脉插管化疗提高妇科恶性肿瘤疗效探讨[J]. 中华妇产科杂志, 1992,27: 270.
[3] Itamochi H, Kigawa J, Terakawa N. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma [J]. Cancer Sci, 2008, 99: 653 658.
[4] 熊玉英, 朱有成. 卵巢癌术前介入化疗的应用[J]. 海军医学杂志, 2002, 23: 319 320.
[5] 王丽玲, 丁瑞亮, 刘秀芳, 等. 介入及腹腔灌注治疗晚期卵巢癌大量顽固性腹水[J]. 中国中西医结合外科杂志, 2002, 8: 97 98.
[6] 孙 勇, 倪才方, 刘一之, 等. 肠系膜下动脉在晚期卵巢癌及其术后复发介入治疗中的价值[J]. 介入放射学杂志, 2009, 18: 305 306.
[7] Martin RC.G., Joshi J, Robbins K, et al. Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with DrugEluting Beads, Irinotecan(DEBIRI): MultiInstitutional Registry [J]. J Oncol, 2009, doi:10,1155/2009/539795.
[8] Gulec SA, Pennington K, Hall M, et al. Preoperqtiue Y90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections[J]. World J Sur Oncol, 2009, 7: 6.
[9] Hilgard P, Hamami M, Fouly AE, et al. Radioembolization with yttrium90 glass microspheres in hepatocellular carcinoma: European experience on safety and longterm survival[J]. Hepatology,2010, 52: 1741 1749.
相似文献/References:
[1]孙勇,倪才方,刘一之,等.肠系膜下动脉在晚期卵巢癌及其术后复发介入治疗中的价值[J].介入放射学杂志,2009,(04):305.
SUN Yong,NI Caifang,LIU Yizhi,et al.The significance of inferior mesenteric artery in the interventional treatment for unresectable and recurrent ovarian carcinoma[J].journal interventional radiology,2009,(05):305.